News in Brief

Concept Life Sciences doubles capacity at analytical services facility

By Melissa Fassbender contact

- Last updated on GMT

(Image: Concept Life Sciences)
(Image: Concept Life Sciences)

Related tags: Chromatography

The drug discovery, development, and analytical services company has invested £250,000 ($338,000) in new equipment at its East Kilbride analytical services site.

According to the company, the investment doubles capacity across several capabilities, including GC/MS (Gas Chromatography/Mass Spectrometry), GC/MS headspace (for analysis of volatile compounds), GCxGC (comprehensive two-dimensional gas chromatography), and metal and anion analysis.

The company also expects to increase its headcount at the site by eight, in order to support the increase in capacity and workload.

Concept Life Sciences also invested £250,000 ($338,000) in new instrumentation added to the East Kilbride facility last year.

Related news

Show more

Related products

show more

Has EDC Kept Up With Changes In Clinical Trials?

Has EDC Kept Up With Changes In Clinical Trials?

Oracle Health Sciences | 14-Dec-2020 | Technical / White Paper

In just a few decades, clinical trials have changed dramatically. Twenty years ago, most of the data used in clinical research was entered on paper, but...

Liver Disease Capabilities

Liver Disease Capabilities

Q² Solutions | 01-Oct-2020 | Clinical Study

We integrate therapeutic insights, state-of-the-art technologies, best-in-class methods and quality systems to optimize NAFLD & NASH study design,...

CAR-T Cell Therapy

CAR-T Cell Therapy

Q² Solutions | 01-Sep-2020 | Clinical Study

Cell therapy involves the transfer of genetically altered cells into a patient. As a global central laboratory services organization, we provide testing...

Related suppliers

Follow us

Products

View more

Webinars